Jack Winfred Wylie, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 450 S Willard St, Suite 105, Cottonwood, AZ 86326 Phone: 928-634-1112 Fax: 928-634-1117 |
Brian T Duggan, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 S Willard St, Cottonwood, AZ 86326 Phone: 928-639-6025 Fax: 928-634-1117 |
Dr. William Hallier, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 S Willard St, Cottonwood, AZ 86326 Phone: 928-639-6025 Fax: 928-634-1117 |
Dr. David G Van De Wyngaerde, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 S Willard St, Cottonwood, AZ 86326 Phone: 928-639-7960 |
Richard Cobden, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 708 Cove Pkwy, Cottonwood, AZ 86326 Phone: 907-374-6602 Fax: 800-877-5680 |
Dr. Allen D Boyd, MD Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 450 S Willard St, Suite 105, Cottonwood, AZ 86326 Phone: 928-634-1112 Fax: 928-634-1117 |
News Archive
People with obsessive-compulsive disorder (OCD) are distracted by obsessive thoughts that cause intense anxiety.
Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected people, it cannot eliminate reservoirs of HIV that persist in latently infected immune cells.
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
"Circumcision reduces a man's risk of acquiring and transmitting HIV and other sexually transmitted diseases, and now researchers have found a possible explanation: the procedure reduces the quantity and diversity of bacteria at the head of the penis," the New York Times' "Well" blog reports (Bakalar, 4/18).
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
› Verified 5 days ago